Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Burt Nabors

Showing results (31-40 of 152) with videos related to

Pageof 16
Sort By:
CNS Oncology|December 15, 2018
An early feasibility study of the Nativis Voyager<sup>®</sup> device in patients with recurrent glioblastoma: first cohort in USCharles Cobbs, Edward McClay, J Paul Duic, et al.
Future Oncology (London, England)|March 23, 2011
Cilengitide: an RGD pentapeptide ανβ3 and ανβ5 integrin inhibitor in development for glioblastoma and other malignanciesDavid A Reardon, Bart Neyns, Michael Weller, et al.
Clinical Lymphoma & Myeloma|January 19, 2007
Case report of a patient with primary central nervous system lymphoma treated with radioimmunotherapyJatin J Shah, Ruby Meredith, Sui Shen, et al.
Cancer Research|July 23, 2003
Tumor necrosis factor alpha induces angiogenic factor up-regulation in malignant glioma cells: a role for RNA stabilization and HuRL Burt Nabors, Esther Suswam, Yuanyuan Huang, et al.
Nutrition and Cancer|June 25, 2016
Pilot Study to Explore the Accuracy of Current Prediction Equations in Assessing Energy Needs of Patients with Newly Diagnosed Glioblastoma MultiformeRebecca B Little, Robert A Oster, Betty E Darnell, et al.
International Journal of Cancer|April 14, 2019
Use of metformin and outcome of patients with newly diagnosed glioblastoma: Pooled analysisCorinna Seliger, Els Genbrugge, Thierry Gorlia, et al.
Targeted Oncology|September 8, 2010
Targeting integrins in malignant gliomaGhazaleh Tabatabai, Michael Weller, Burt Nabors, et al.
International Journal of Cancer|November 8, 2022
Association of antidepressant drug use with outcome of patients with glioblastomaCorinna Seliger, Felix Boakye Oppong, Florence Lefranc, et al.
Human Gene Therapy. Clinical Development|June 18, 2016
Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or GliosarcomaDaxa M Patel, Paul M Foreman, L Burt Nabors, et al.
Pediatric Blood & Cancer|October 1, 2010
Treatment of primary CNS lymphoma with high-dose methotrexate in immunocompetent pediatric patientsAmish C Shah, David R Kelly, L Burt Nabors, et al.
Pageof 16

Showing results (31-40 of 152) with videos related to

Sort By:
Pageof 16
CNS Oncology|December 15, 2018
An early feasibility study of the Nativis Voyager<sup>®</sup> device in patients with recurrent glioblastoma: first cohort in USCharles Cobbs, Edward McClay, J Paul Duic, et al.
Future Oncology (London, England)|March 23, 2011
Cilengitide: an RGD pentapeptide ανβ3 and ανβ5 integrin inhibitor in development for glioblastoma and other malignanciesDavid A Reardon, Bart Neyns, Michael Weller, et al.
Clinical Lymphoma & Myeloma|January 19, 2007
Case report of a patient with primary central nervous system lymphoma treated with radioimmunotherapyJatin J Shah, Ruby Meredith, Sui Shen, et al.
Cancer Research|July 23, 2003
Tumor necrosis factor alpha induces angiogenic factor up-regulation in malignant glioma cells: a role for RNA stabilization and HuRL Burt Nabors, Esther Suswam, Yuanyuan Huang, et al.
Nutrition and Cancer|June 25, 2016
Pilot Study to Explore the Accuracy of Current Prediction Equations in Assessing Energy Needs of Patients with Newly Diagnosed Glioblastoma MultiformeRebecca B Little, Robert A Oster, Betty E Darnell, et al.
International Journal of Cancer|April 14, 2019
Use of metformin and outcome of patients with newly diagnosed glioblastoma: Pooled analysisCorinna Seliger, Els Genbrugge, Thierry Gorlia, et al.
Targeted Oncology|September 8, 2010
Targeting integrins in malignant gliomaGhazaleh Tabatabai, Michael Weller, Burt Nabors, et al.
International Journal of Cancer|November 8, 2022
Association of antidepressant drug use with outcome of patients with glioblastomaCorinna Seliger, Felix Boakye Oppong, Florence Lefranc, et al.
Human Gene Therapy. Clinical Development|June 18, 2016
Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or GliosarcomaDaxa M Patel, Paul M Foreman, L Burt Nabors, et al.
Pediatric Blood & Cancer|October 1, 2010
Treatment of primary CNS lymphoma with high-dose methotrexate in immunocompetent pediatric patientsAmish C Shah, David R Kelly, L Burt Nabors, et al.
Pageof 16